Literature DB >> 24371256

Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines.

K Kolibab1, A Yang, M Parra, S C Derrick, S L Morris.   

Abstract

Clinical studies have suggested that the enumeration of mycobacteria by using automated liquid systems is a faster and simpler alternative to quantitative cultures. Here, we show that the time to detection of M. tuberculosis growth as measured with the MGIT 320 liquid culture system inversely correlates with CFU determinations from culture on solid media and that mycobacterial quantification using the MGIT system is faster and easier to perform than CFU plating.

Entities:  

Mesh:

Year:  2013        PMID: 24371256      PMCID: PMC3957671          DOI: 10.1128/CVI.00742-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  18 in total

1.  A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity.

Authors:  Steven C Derrick; Amy Li Yang; Sheldon L Morris
Journal:  Vaccine       Date:  2004-12-21       Impact factor: 3.641

Review 2.  Preclinical testing of new vaccines for tuberculosis: a comprehensive review.

Authors:  Ian M Orme
Journal:  Vaccine       Date:  2005-08-08       Impact factor: 3.641

3.  Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials.

Authors:  Sabine Rüsch-Gerdes; Gaby E Pfyffer; Manuel Casal; Maureen Chadwick; Salman Siddiqi
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis.

Authors:  M D Epstein; N W Schluger; A L Davidow; S Bonk; W N Rom; B Hanna
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

Review 5.  BCG: the challenge continues.

Authors:  P E Fine
Journal:  Scand J Infect Dis       Date:  2001

6.  Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis.

Authors:  Marcela Parra; Amy L Yang; JaeHyun Lim; Kristopher Kolibab; Steven Derrick; Nathalie Cadieux; Liyanage P Perera; William R Jacobs; Michael Brennan; Sheldon L Morris
Journal:  Clin Vaccine Immunol       Date:  2009-05-20

7.  Evaluation of the BD Bactec MGIT 320 system for detection of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  Abigail Duque; S-Y Grace Lin; Edward Desmond; Somsak Rienthong; Dhanida Rienthong; Chanattree Boonin
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

8.  Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting.

Authors:  C Pheiffer; N M Carroll; N Beyers; P Donald; K Duncan; P Uys; P van Helden
Journal:  Int J Tuberc Lung Dis       Date:  2008-07       Impact factor: 2.373

9.  Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  C M S Giampaglia; M C Martins; G B de Oliveira Vieira; S A Vinhas; M A da Silva Telles; M Palaci; A G Marsico; D J Hadad; F C Q Mello; L de Souza Fonseca; A Kritski
Journal:  Int J Tuberc Lung Dis       Date:  2007-09       Impact factor: 2.373

10.  Rapid and reliable method for quantification of Mycobacterium paratuberculosis by use of the BACTEC MGIT 960 system.

Authors:  Sung Jae Shin; Jun Hee Han; Elizabeth J B Manning; Michael T Collins
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

View more
  7 in total

1.  Anti-tuberculosis effect of isoniazid scales accurately from zebrafish to humans.

Authors:  Rob C van Wijk; Wanbin Hu; Sharka M Dijkema; Dirk-Jan van den Berg; Jeremy Liu; Rida Bahi; Fons J Verbeek; Ulrika S H Simonsson; Herman P Spaink; Piet H van der Graaf; Elke H J Krekels
Journal:  Br J Pharmacol       Date:  2020-11-03       Impact factor: 8.739

2.  Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High Mortality.

Authors:  Jotam G Pasipanodya; Mwenya Mubanga; Mpiko Ntsekhe; Shaheen Pandie; Beki T Magazi; Freedom Gumedze; Landon Myer; Tawanda Gumbo; Bongani M Mayosi
Journal:  EBioMedicine       Date:  2015-09-21       Impact factor: 8.143

3.  Investigation of Immune Biomarkers Using Subcutaneous Model of M. tuberculosis Infection in BALB/c Mice: A Preliminary Report.

Authors:  Aliabbas A Husain; Hatim F Daginawala; Shubangi R Warke; Devanand R Kalorey; Nitin V Kurkure; Hemant J Purohit; Girdhar M Taori; Rajpal S Kashyap
Journal:  Immune Netw       Date:  2015-04-23       Impact factor: 6.303

4.  Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.

Authors:  Christina Jensen; Line Lindebo Holm; Erik Svensson; Claus Aagaard; Morten Ruhwald
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

Review 5.  The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

Authors:  Michael J Brennan; Rachel Tanner; Sheldon Morris; Thomas J Scriba; Jacqueline M Achkar; Andrea Zelmer; David A Hokey; Angelo Izzo; Sally Sharpe; Ann Williams; Adam Penn-Nicholson; Mzwandile Erasmus; Elena Stylianou; Daniel F Hoft; Helen McShane; Helen A Fletcher
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

6.  The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells.

Authors:  Rachel Tanner; Emily Hoogkamer; Julia Bitencourt; Andrew White; Charelle Boot; Claudia C Sombroek; Stephanie A Harris; Matthew K O'Shea; Daniel Wright; Rachel Wittenberg; Charlotte Sarfas; Iman Satti; Frank A W Verreck; Sally A Sharpe; Helen A Fletcher; Helen McShane
Journal:  F1000Res       Date:  2021-03-30

7.  Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium.

Authors:  Gül Kilinç; Kimberley V Walburg; Kees L M C Franken; Merel L Valkenburg; Alexandra Aubry; Mariëlle C Haks; Anno Saris; Tom H M Ottenhoff
Journal:  Front Cell Infect Microbiol       Date:  2022-06-24       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.